Clearlake and Imperium Release: Entelos, Inc. Announces Recapitalization and Significant Capital Infusion to Drive Future Growth  
1/11/2012 6:34:42 AM

SAN MATEO, Calif.--(BUSINESS WIRE)--Entelos Holding Corporation (“Entelos” or the “Company”), a premier provider of in silico modeling and simulation products and services that help pharmaceutical and consumer product companies make informed decisions in their product development process, today announced that it has completed a recapitalization and has received a significant capital infusion led by Clearlake Capital Group, L.P. (“Clearlake”) with participation by the Company’s existing investor, Imperium Partners Group, LLC (“Imperium”).